Position in ARCT
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$193,838
+$15,198 QoQ
Shares Held
28,845
+24.7% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 133 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. ARCT ranks #115 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in ARCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,838 | 28,845 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $178,640 | 23,140 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $142,982 | 23,325 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $241,451 | 13,101 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $190,193 | 14,619 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $211,259 | 19,949 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $371,659 | 21,901 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $506,859 | 21,838 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $733,300 | 30,115 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $945,999 | 28,013 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $889,776 | 28,220 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $774,752 | 30,323 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $559,948 | 19,524 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $214,608 | 14,481 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $246,755 | 15,677 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $730,669 | 27,102 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,128,990 | 30,505 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,541,335 | 32,259 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,173,063 | 34,665 | Shares | Defined | 2021-08-11 | |
| 2020-09-30 | $1,334,232 | 31,101 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,306,523 | 27,953 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||